Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: a multicenter analysis from the Campania Oncological Network (ROC). - Tambaro R; Calvanese G; Muto A; Formisano L; Di Lorenzo G; Buonerba C; Bosso D; Sabbatino F; Coppola E; Di Napoli M; Rossetti S; Pisano C; et al. (BMC cancer, 2026)